IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance

SOUTH SAN FRANCISCO, Calif., Jan. 7, 2024 /PRNewswire/ — IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 corporate guidance and program updates. 42nd Annual J.P. Morgan Healthcare ConferenceTuesday, January 9th, 2024 […]

Related Keywords

Yujiros Hata ,Anupam Rama ,Andres Ruiz Briseno ,Werner Helicase Inhibitor Development ,Nasdaq ,Biosciences Inc ,Biotechnology Equity Research ,Exchange Commission ,Healthcare Conference ,Chief Executive Officer ,Managing Director ,Equity Research ,Pol Theta Helicase ,Werner Helicase Inhibitor Development Candidate ,Investor Relations ,Quarterly Report ,Vice President ,